The kind of hearing loss that sneaks up on you
Most people think of hearing loss as an age thing — the slow fade that starts somewhere in your sixties. But a less-known cause can begin in your twenties or thirties, affects women more often than men, and often runs in families. It is called otosclerosis, and it happens when a tiny bone in the middle ear — the stapes — gets locked in place by abnormal bone growth. Sound vibrations can't pass through anymore.
Patients often describe it the same way: conversations at parties started sounding muffled. They could hear fine on the phone, because phone speakers send vibrations directly into the ear canal. Over years, the hearing faded further.
Why now
A research team in Turkey just published something that could change how we think about this condition. They asked a simple question: if otosclerosis involves inflammation of bone in the ear, does that inflammation leave a fingerprint in the blood?
They looked at two numbers that any standard complete blood count (CBC) already measures:
- NLR — Neutrophil-to-Lymphocyte Ratio
- SII — Systemic Immune-Inflammation Index, calculated as (platelets × neutrophils) ÷ lymphocytes
Both numbers are already used by doctors studying heart disease, cancer prognosis, and autoimmune conditions. They're free to calculate, because the ingredients come out of every routine CBC.
How the study worked
The team pulled records of 52 adults who had otosclerosis surgery (stapedotomy) between January 2023 and January 2024. For a control group, they used 50 adults who had a completely unrelated nasal septum surgery, so age and general health would be roughly comparable.
Blood samples were drawn at the same time of day (between 8 and 10 a.m.), after an overnight fast — a detail that matters because inflammation markers swing during the day and with recent meals.
What the blood told them
SII was meaningfully higher in the otosclerosis group. The otosclerosis patients averaged 599, compared to 504 in controls — about a 19% difference that held up statistically even after adjusting for age and sex.
NLR was higher too, but the difference did not cross the statistical finish line. A hint, not a verdict.
Interestingly, the individual blood cell counts — neutrophils and platelets alone — looked basically the same between groups. Only when those numbers were combined with lymphocytes (which were slightly lower in otosclerosis patients) did the pattern emerge. That is the whole point of composite scores like SII: they catch subtle shifts that single numbers miss.
Re-engaging with what this actually means
Does this mean a blood test can now diagnose otosclerosis? No. Let's be clear about that.
An ROC analysis — statistical shorthand for "how well does this test distinguish patients from non-patients" — landed at 0.658. That is described as moderate discrimination. A coin flip would score 0.5. A great diagnostic test scores above 0.8. So SII sits firmly in the "interesting clue" zone, not the "you have otosclerosis" zone.
What this finding suggests is something more philosophical: otosclerosis is not purely a local bone problem. It appears to leave a low-grade whole-body inflammatory signature. That could change how scientists think about what actually drives the disease.
What experts are saying
ENT surgeons have long debated whether otosclerosis is driven by genetics, viral infection, autoimmunity, or a mix. A systemic inflammation signal fits best with the autoimmune hypothesis. It does not prove that angle, but it nudges the evidence.
If you have been diagnosed with otosclerosis, this study does not change your treatment plan. Stapedotomy is still the gold-standard surgery, and hearing aids remain a powerful alternative.
If your hearing has been quietly slipping and no one has given you a clear reason yet, two things are worth knowing:
1. Otosclerosis is often missed because it starts young and progresses slowly. An audiogram and a look at your middle ear can reveal it. 2. Your doctor already has your CBC. It cannot diagnose otosclerosis, but in the near future, a flagged SII may become one of several clues that steers an evaluation in the right direction.
The limitations worth naming
This was a retrospective look at a little over 100 people at a single center. The statistical significance was borderline (p = 0.047), meaning this finding needs replication before anyone builds clinical decisions on it. The control group had septoplasty, which is a reasonable match but not a perfectly healthy comparison — people having nose surgery are not entirely free of inflammation themselves.
The authors call the results "exploratory" for exactly these reasons.
The next study worth doing is a prospective one: draw SII on people with early, unexplained hearing loss, follow them for years, and see whether the elevated number predicts an eventual otosclerosis diagnosis. Larger numbers would also clarify whether the blood signal tracks disease severity or surgical outcomes.
If those follow-ups hold up, otosclerosis could join the growing list of conditions where a free number on your lab printout carries more meaning than anyone realized.